Teva Pharmaceutical second-quarter profit rises 5 percent on European sales - - Tulsa, OK - News, Weather, Video and Sports - |

Teva Pharmaceutical second-quarter profit rises 5 percent on European sales

NEW YORK (AP) _ Generic drug maker Teva Pharmaceutical Industries Ltd. said Monday second-quarter profit rose 5 percent, as strong sales in Europe helped outweigh weaker sales in the United States amid fewer new drug launches.

The Israel-based company, which last week announced a planned acquisition of Ivax Corp. that will make it the world's largest generic drug company, reported earnings of $241.2 million, or 36 cents per American depository receipt, compared with $229.5 million, or 34 cents per ADR, in the prior-year period. Sales rose 4 percent to $1.23 billion.

The results matched Wall Street's mean estimate of 36 cents per share, the average view of 23 analysts surveyed by Thomson Financial, on projected revenue of $1.28 billion.

Teva said the sales increase was driven by all of its major operations except for the U.S., its biggest market, where generic operations were hurt by a small number of new product launches and increased competition facing some of its leading generic drugs.
Powered by Frankly
News On 6
303 N. Boston Ave.
Tulsa, OK 74103 is proud to provide Oklahomans with timely and relevant news and information, sharing the stories, pictures and loves of Oklahomans across our great state.
All content © Copyright 2000 - 2018 KOTV. Oklahoma Traveler™ is a registered trademark of Griffin Communications. All Rights Reserved.
For more information on this site, please read our Privacy Policy, and Terms of Service, and Ad Choices.